530
Views
25
CrossRef citations to date
0
Altmetric
Original Article

The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis

, , , , , , , , , & show all
Pages 825-830 | Received 04 Apr 2018, Accepted 23 May 2018, Published online: 03 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Dorit Vedel Ankersen, Petra Weimers, Dorte Marker, Thor Johannesen, Søren Iversen, Berit Lilje, Anja Bråthen Kristoffersen, Sanaz Saboori, Kristine Paridaens, Paal Skytt Andersen, Johan Burisch & Pia Munkholm. (2020) eHealth: Disease activity measures are related to the faecal gut microbiota in adult patients with ulcerative colitis. Scandinavian Journal of Gastroenterology 55:11, pages 1291-1300.
Read now
Mikkel Malham, Katrine Carlsen, Lene Riis, Anders Paerregaard, Ida Vind, Mogens Fenger & Vibeke Wewer. (2019) Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis. Scandinavian Journal of Gastroenterology 54:10, pages 1214-1219.
Read now
Amanda Ricciuto & Anne M. Griffiths. (2019) Clinical value of fecal calprotectin. Critical Reviews in Clinical Laboratory Sciences 56:5, pages 307-320.
Read now
Pontus Karling, David Lundgren, Vincy Eklöf, Richard Palmqvist & Johan Hultdin. (2019) Improved monitoring of inflammatory activity in patients with ulcerative colitis by combination of faecal tests for haemoglobin and calprotectin. Scandinavian Journal of Clinical and Laboratory Investigation 79:5, pages 341-346.
Read now
Jun Kato, Takeichi Yoshida & Sakiko Hiraoka. (2019) Prediction of treatment outcome and relapse in inflammatory bowel disease. Expert Review of Clinical Immunology 15:6, pages 667-677.
Read now

Articles from other publishers (20)

Naohiro Nakamura, Yusuke Honzawa, Shuhei Nishimon, Yasuki Sano, Yutaro Tokutomi, Yuka Ito, Naoto Yagi, Sanshiro Kobayashi, Mamiko Aoi, Tomomitsu Tahara, Norimasa Fukata, Toshiro Fukui & Makoto Naganuma. (2023) Combined serum albumin, fecal immunochemical test, and leucine-rich alpha-2 glycoprotein levels for predicting prognosis in remitting patients with ulcerative colitis. Scientific Reports 13:1.
Crossref
Kun He & Dong Wu. (2023) The treatment principles and targets for intestinal Behcet’s disease. Therapeutic Advances in Gastroenterology 16, pages 175628482311672.
Crossref
Xiaojun Li, Lamei Yan, Xuehong Wang, Chunhui Ouyang, Chunlian Wang, Jun Chao, Jie Zhang & Guanghui Lian. (2022) Predictive models for endoscopic disease activity in patients with ulcerative colitis: Practical machine learning-based modeling and interpretation. Frontiers in Medicine 9.
Crossref
Meyya Bouazzi, Nina F. Bak, Jørgen Agnholt, Vibeke Wewer, Mikkel Malham & Mia Bendix. (2022) Paediatric Crohn’s Disease Patients Have Increased Inflammatory Markers Compared to Adult Patients prior to Biological Treatment. GastroHep 2022, pages 1-11.
Crossref
Panu Wetwittayakhlang, Livia Lontai, Lorant Gonczi, Petra A. Golovics, Gustavo Drügg Hahn, Talat Bessissow & Peter L. Lakatos. (2021) Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?. Journal of Clinical Medicine 10:23, pages 5551.
Crossref
Kentaro Moriichi, Mikihiro Fujiya & Toshikatsu Okumura. (2020) The endoscopic diagnosis of mucosal healing and deep remission in inflammatory bowel disease. Digestive Endoscopy 33:7, pages 1008-1023.
Crossref
Jared Matson, Sonia Ramamoorthy & Nicole E. Lopez. (2021) The Role of Biomarkers in Surgery for Ulcerative Colitis: A Review. Journal of Clinical Medicine 10:15, pages 3362.
Crossref
Sen Yagi, Shinya Furukawa, Kana Shiraishi, Yu Hashimoto, Kazuhiro Tange, Kenichirou Mori, Tomoyuki Ninomiya, Seiyuu Suzuki, Naozumi Shibata, Hidehiro Murakami, Katsuhisa Ohashi, Aki Hasebe, Hideomi Tomida, Yasunori Yamamoto, Eiji Takeshita, Yoshio Ikeda & Yoichi Hiasa. (2021) Effect of disease duration on the association between serum albumin and mucosal healing in patients with ulcerative colitis. BMJ Open Gastroenterology 8:1, pages e000662.
Crossref
Mariusz A. Bromke, Katarzyna Neubauer, Radosław Kempiński & Małgorzata Krzystek-Korpacka. (2021) Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis. Journal of Clinical Medicine 10:10, pages 2203.
Crossref
Allison Ross EckardHeather Y. HughesNancy L. HagoodMary Ann O'Riordan, Danielle Labbato, Julia C. Kosco, Sarah E. Scott & Grace A. McComsey. (2021) Fecal Calprotectin Is Elevated in HIV and Related to Systemic Inflammation. JAIDS Journal of Acquired Immune Deficiency Syndromes 86:2, pages 231-239.
Crossref
Ludimilla dos Reis Malvão, Kalil Madi, Barbara Cathalá Esberard, Renata Fernandes de Amorim, Kelly dos Santos Silva, Katia Farias e Silva, Heitor Siffert Pereira de Souza & Ana Teresa Pugas Carvalho. (2021) Fecal calprotectin as a noninvasive test to predict deep remission in patients with ulcerative colitis. Medicine 100:3, pages e24058.
Crossref
雪莲 杨. (2021) Current Status of Serological Markers in Predicting Mucosal Healing in Ulcerative Colitis. Advances in Clinical Medicine 11:11, pages 4997-5001.
Crossref
Bing-Jie Xiang, Min Jiang, Ming-Jun Sun & Cong Dai. (2021) Optimal Range of Fecal Calprotectin for Predicting Mucosal Healing in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Visceral Medicine 37:5, pages 338-348.
Crossref
Guillaume Bonnaud, Yoram Bouhnik, Hervé Hagege, Xavier Hebuterne, Benjamin Pariente, Xavier Roblin & Laurent Peyrin-Biroulet. (2020) Monitoring of inflammatory bowel disease in 2019: A French consensus for clinical practice. Digestive and Liver Disease 52:7, pages 704-720.
Crossref
Małgorzata Krzystek-Korpacka, Radosław Kempiński, Mariusz Bromke & Katarzyna Neubauer. (2020) Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults. Diagnostics 10:6, pages 367.
Crossref
Makoto Naganuma, Taku Kobayashi, Masanao Nasuno, Satoshi Motoya, Shingo Kato, Katsuyoshi Matsuoka, Ryota Hokari, Chikako Watanabe, Hirotsugu Sakamoto, Hironori Yamamoto, Makoto Sasaki, Kenji Watanabe, Hideki Iijima, Yutaka Endo, Hitoshi Ichikawa, Keiji Ozeki, Satoshi Tanida, Nobuhiro Ueno, Mikihiro Fujiya, Minako Sako, Ken Takeuchi, Shinya Sugimoto, Takayuki Abe, Toshifumi Hibi, Yasuo Suzuki & Takanori Kanai. (2020) Significance of Conducting 2 Types of Fecal Tests in Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology 18:5, pages 1102-1111.e5.
Crossref
Britta Siegmund. (2020) Are Serum-Based Markers Going to Replace Faecal Neutrophil Markers in Ulcerative Colitis?. Journal of Crohn's and Colitis 14:2, pages 151-152.
Crossref
Rasmus Goll, Richard Heitmann, Øystein Kittel Moe, Katrine Carlsen & Jon Florholmen. (2019) Head to head comparison of two commercial fecal calprotectin kits as predictor of Mayo endoscopic sub-score and mucosal TNF expression in ulcerative colitis. PLOS ONE 14:12, pages e0224895.
Crossref
Arno R. Bourgonje, Julius Z. H. von Martels, Ruben Y. Gabriëls, Tjasso Blokzijl, Manon Buist-Homan, Janette Heegsma, Bernadien H. Jansen, Hendrik M. van Dullemen, Eleonora A. M. Festen, Rinze W. F. ter Steege, Marijn C. Visschedijk, Rinse K. Weersma, Paul de Vos, Klaas Nico Faber & Gerard Dijkstra. (2019) A Combined Set of Four Serum Inflammatory Biomarkers Reliably Predicts Endoscopic Disease Activity in Inflammatory Bowel Disease. Frontiers in Medicine 6.
Crossref
Katrine Carlsen, Mikkel Malham, Lars Folmer Hansen, Jens Jakob Herrche Petersen, Anders Paerregaard, Gunnar Houen & Vibeke Wewer. (2019) Serum Calprotectin in Adolescents With Inflammatory Bowel Disease—A Pilot Investigation. Journal of Pediatric Gastroenterology and Nutrition 68:5, pages 669-675.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.